午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Venetoclax-N-Oxide
Venetoclax-N-Oxide
  • Venetoclax-N-Oxide
  • Venetoclax-N-Oxide
  • Venetoclax-N-Oxide
  • Venetoclax-N-Oxide
  • Venetoclax-N-Oxide

Venetoclax-N-Oxide NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-15

Product Details

Product Name: Venetoclax-N-Oxide CAS No.: 2469279-00-1
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/15
Molecular formula: C45H50ClN7O8S

Venetoclax-N-Oxide;2469279-00-1

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

Product Information

  • Product Number: V028002

  • English Name: Venetoclax-N-Oxide

  • English Alias: 4-(3-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(((3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)sulfonyl)carbamoyl)phenyl)-1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine 1-oxide

  • CAS Number: 2469279-00-1

  • Molecular Formula: C??H??ClN?O?S

  • Molecular Weight: 884.44

Advantages

As an N-oxide derivative impurity of Venetoclax, this compound has the following advantages:


  • Well-defined and distinct structure: Contains piperazine N-oxide (-N?-O?), pyrrolo[2,3-b]pyridine ring, nitrobenzenesulfonamide, and chlorobiphenyl moieties, differing from Venetoclax by N-oxidation of the piperazine nitrogen. It can be accurately identified by techniques such as HPLC and LC-MS, providing a specific marker for impurity detection;

  • High stability and traceability: The polar structure of N-oxide is stable under neutral conditions. As a product of Venetoclax storage or oxidative degradation, it directly reflects the degree of oxidative deterioration, improving the accuracy of quality tracing;

  • High detection sensitivity: The unique retention behavior of nitro and sulfonamide groups in reversed-phase chromatography, combined with characteristic mass response of N-oxide (e.g., m/z 885 [M+H]?), enables trace analysis via LC-MS, compatible with detection systems for complex-structured drugs.

Applications

  • Pharmaceutical quality control: Used as an impurity reference standard to identify and quantify Venetoclax-N-Oxide in Venetoclax APIs and formulations, ensuring residual N-oxide impurities meet quality standards;

  • Stability evaluation: Assessing the oxidative stability of Venetoclax formulations under light and high temperature by monitoring impurity content, supporting the development of appropriate storage conditions;

  • Degradation pathway research: Exploring the oxidative degradation mechanism of Venetoclax in aerobic environments, clarifying the formation conditions of N-oxide impurities to optimize antioxidant production processes.

Background Description

Venetoclax is a B-cell lymphoma 2 (BCL-2) inhibitor used to treat hematologic malignancies such as chronic lymphocytic leukemia, with a structure containing an oxidizable piperazine ring. During storage (especially when exposed to air, light, or high temperature), the piperazine nitrogen may be oxidized to form an N-oxide derivative, namely Venetoclax-N-Oxide. N-oxide impurities may affect drug stability and target-binding activity, making their control a key part of Venetoclax quality assurance.

Research Status

Current research focuses on:


  • Detection method optimization: Using UPLC-MS/MS with optimized parameters for N-oxide characteristic fragments (e.g., pyrrolopyridine ring cleavage ions) to achieve ultra-trace detection (ppb level);

  • Oxidation kinetics: Studying impurity formation rates under varying pH and oxygen levels to identify key drivers (e.g., metal ion catalysis) of piperazine oxidation in Venetoclax;

  • Activity impact assessment: Comparing BCL-2 binding affinity between this impurity and Venetoclax via in vitro assays to evaluate potential effects on drug efficacy;

  • Stabilization strategies: Developing oxygen-barrier packaging and antioxidant additives to minimize N-oxide impurity formation in Venetoclax products during storage.


We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/100g
VIP1Y
Cangzhou Kangrui Pharma Tech Co. Ltd.,
2024-11-19
$0.00/1kg
VIP3Y
Hangzhou ICH Biofarm Co., Ltd
2023-06-30
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-04-28
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-04-28
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-04-03
INQUIRY